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MicroRNAs (miRNAs) interact with target mRNAs at specific sites to induce cleavage of the message or inhibit
translation. The specific function of most mammalian miRNAs is unknown. We have predicted target sites on the 39
untranslated regions of human gene transcripts for all currently known 218 mammalian miRNAs to facilitate focused
experiments. We report about 2,000 human genes with miRNA target sites conserved in mammals and about 250
human genes conserved as targets between mammals and fish. The prediction algorithm optimizes sequence
complementarity using position-specific rules and relies on strict requirements of interspecies conservation.
Experimental support for the validity of the method comes from known targets and from strong enrichment of
predicted targets in mRNAs associated with the fragile X mental retardation protein in mammals. This is consistent
with the hypothesis that miRNAs act as sequence-specific adaptors in the interaction of ribonuclear particles with
translationally regulated messages. Overrepresented groups of targets include mRNAs coding for transcription factors,
components of the miRNA machinery, and other proteins involved in translational regulation, as well as components of
the ubiquitin machinery, representing novel feedback loops in gene regulation. Detailed information about target
genes, target processes, and open-source software for target prediction (miRanda) is available at www.microrna.org.
Our analysis suggests that miRNA genes, which are about 1% of all human genes, regulate protein production for 10%
or more of all human genes.
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Introduction
The Functions of MicroRNAs
In the past three years, several hundred novel genes
encoding transcripts containing short double-stranded RNA
hairpins, named microRNAs (miRNAs), were identiﬁed in
plants and animals (Lee et al. 1993; Reinhart et al. 2000, 2002;
Lagos-Quintana et al. 2001, 2002, 2003; Lau et al. 2001; Lee
and Ambros 2001; Llave et al. 2002a; Mette et al. 2002;
Mourelatos et al. 2002; Park et al. 2002; Ambros et al. 2003b;
Aravin et al. 2003; Brennecke et al. 2003; Dostie et al. 2003;
Grad et al. 2003; Houbaviy et al. 2003; Lai et al. 2003; Lim et
al. 2003a, 2003b; Palatnik et al. 2003). More recently, miRNAs
have also been identiﬁed in a large DNA virus, the Epstein
Barr virus, and are likely to be found in other viruses (Pfeffer
et al. 2004). The cellular functions of most animal miRNAs
are unknown.
More than ten years after the discovery of the ﬁrst miRNA
gene, lin-4 (Chalﬁe et al. 1981; Lee et al. 1993), we know that
miRNA genes constitute about 1%–2% of the known genes in
eukaryotes. Investigation of miRNA expression combined
with genetic and molecular studies in Caenorhabditis elegans,
Drosophila melanogaster, and Arabidopsis thaliana have identiﬁed
the biological functions of several miRNAs (recent review,
Bartel 2004). In C. elegans, lin-4 and let-7 were ﬁrst discovered
as key regulators of developmental timing in early larval
developmental transitions (Ambros 2000; Abrahante et al.
2003; Lin et al. 2003; Vella et al. 2004). More recently lsy-6 was
shown to determine the left–right asymmetry of chemo-
receptor expression (Johnston and Hobert 2003). In D.
melanogaster, miR-14 has a role in apoptosis and fat metabo-
lism (Xu et al. 2003) and the bantam miRNA targets the gene
hid involved in apoptosis and growth control (Brennecke et al.
2003). In mouse, miR-181a modulates hematopoietic differ-
entiation (Chen et al. 2004), and miR-196 directs the cleavage
of Hox-B8 transcripts (Yekta et al. 2004).
miRNAs have speciﬁcity. In a range of organisms, miRNAs
are differentially expressed in developmental stages, cell
types, and tissues (Lee and Ambros 2001; Lagos-Quintana et
al. 2002; Sempere et al. 2004). In particular, differential
expression has been observed in mammalian organs (Lagos-
Quintana et al. 2002; Krichevsky et al. 2003; Sempere et al.
2004) and embryonic stem cells (Houbaviy et al. 2003).
Estimates in worm show that there are approximately 1,000
molecules of miRNA per cell, with some cells exceeding
50,000 molecules (Lim et al. 2003b). This dynamic range of
regulation of miRNA expression underscores the regulatory
functional importance of miRNAs.
The Mechanism of miRNA Action
How do miRNAs pair with their target messages? miRNAs
cause the translational repression or cleavage of target
messages (Doench and Sharp 2004). Some miRNAs may
behave like small interfering RNAs (siRNAs) that direct
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in the siRNA:mRNA target duplex (Tuschl et al. 1999; Zamore
et al. 2000; Elbashir et al. 2001; Hutva ´gner and Zamore 2002a;
Llave et al. 2002b; Martinez et al. 2002; Bartel 2004; Yekta et
al. 2004). It appears that the extent of base pairing between
the small RNA and the mRNA determines the balance
between cleavage and degradation (Hutva ´gner and Zamore
2002a). Recent examples of cleavage of target messages are, in
mouse, mir-196 guiding cleavage of Hox-B8 transcripts (Yekta
et al. 2004) and, in Epstein Barr virus, miR-BART2, a virus-
encoded miRNA, guiding the cleavage of transcripts for virus
DNA polymerase (gene BALF5) (Pfeffer et al. 2004). While
cleavage of mRNA is a straightforward process, the details of
the mechanism of translational repression are unknown.
The following rules for matches between miRNA and target
messages have been deduced from a range of experiments. (1)
Asymmetry: experimentally veriﬁed miRNA target sites
indicate that the 59 end of the miRNA tends to have more
bases complementary to the target than its 39 end. Loopouts
in either the mRNA or the miRNA between positions 9 and
14 of the miRNA have been observed or deduced (Brennecke
et al. 2003; Johnston and Hobert 2003; Lin et al. 2003; Vella et
al. 2004). Recent experiments show some correlation between
the level of translational repression and the free energy of
binding of the ﬁrst eight nucleotides in the 59 region of the
miRNA (Doench and Sharp 2004). However, conﬁrmed
miRNA:mRNA target pairs can have mismatches in this
region (Moss et al. 1997; Johnston and Hobert 2003). (2) G:U
wobbles: wobble base pairs are less common in the 59 end of a
miRNA:mRNA duplex, and recent work shows a dispropor-
tionate penalty of G:U pairing relative to standard thermo-
dynamic considerations (Doench and Sharp 2004). (3)
Cooperativity of binding: many miRNAs can bind to one
gene (Reinhart et al. 2000; Ambros 2003; Vella et al. 2004),
and the target sites may overlap to some degree (Doench and
Sharp 2004).
Given the overlap between the siRNA and miRNA path-
ways, it is reasonable to assume that rules of regulation in the
siRNA pathway will partly apply to miRNA target recognition
(Hutva ´gner and Zamore 2002b; Boutet et al. 2003; Doench et
al. 2003). Lately, detailed characteristics associated with
siRNA functionality were identiﬁed: low G/C content, a bias
towards low internal stability at the39 terminus, lack of
inverted repeats, and strand base preferences (positions 3, 10,
13, and 19) (Jackson et al. 2003; Reynolds et al. 2004). These
observations may provide clues for better quantitative
description of miRNA:mRNA interaction. Regions adjacent
or near to the target site can be important for miRNA
speciﬁcity. In lin-41, a 27-nucleotide (nt) intervening se-
quence between two consecutive let-7 sites is necessary for its
regulation (Vella et al. 2004). Because of lack of conservation
of this 27-nt intervening sequence in C. briggsae, incorpo-
ration of a corresponding rule is premature.
Maturation of miRNAs and Assembly in RNA-Induced
Silencing Complex
miRNAs are transcribed as longer precursors, termed pre-
miRNAs (Lee et al. 2002), sometimes in clusters and
frequently in introns (25% of human miRNAs; Table S1).
Upon transcription, miRNAs undergo nuclear cleavage by the
RNase III endonuclease Drosha, producing the 60–70-nt
stem-loop precursor miRNA (pre-miRNA) with a 59 phos-
phate and a 2-nt 39 overhang (Lee et al. 2003). The pre-
miRNA is subsequently transported across the nuclear
membrane, dependent on the protein exportin 5 (Lund et
al. 2003; Yi et al. 2003). Dicer cleaves the pre-miRNA in the
cytoplasm about two helical turns away from the ends of the
pre-miRNA stem loop, producing double-stranded RNA. A
helicase unwinds the cleaved double-stranded RNA in a
strand-speciﬁc direction (Khvorova et al. 2003; Schwarz et al.
2003).
One of the unwound strands is subsequently incorporated
into a ribonuclear particle (RNP) complex, RNA-induced
silencing complex (RISC) (Hutva ´gner and Zamore 2002a;
Martinez et al. 2002). Every RISC contains a member of the
Argonaute protein family, which tightly binds the RNA in the
complex (Hammond et al. 2001; Hutva ´gner and Zamore
2002a; Martinez et al. 2002; Mourelatos et al. 2002). There are
at least eight members of the Argonaute family in mammals
(Sasaki et al. 2003), and only a small subset has been
functionally characterized. The Argonautes and Dicer bind
single-stranded RNA via their PAZ domains (Lingel et al.
2003; Sasaki et al. 2003; Song et al. 2003; Yan et al. 2003), and
the known structures of the PAZ domains may have
implications for prediction of miRNA targets (Lingel et al.
2003; Song et al. 2003; Yan et al. 2003).
Association of mRNAs and miRNAs with Fragile X Mental
Retardation Protein
Among the prime candidates for miRNA control are the
genes that are posttranscriptionally regulated. The mRNA-
binding protein fragile X mental retardation protein (FMRP)
is involved in the regulation of local protein synthesis (Antar
and Bassell 2003) and binds 4% of mRNAs expressed in the
rat brain, as tested in vitro (Brown et al. 2001). The loss of
function of FMRP causes fragile X syndrome, the most
prevalent form of mental retardation (one in every 2,000
children). Over the past three years a number of different
groups have identiﬁed in vivo mRNA cargoes of FMRP. The
Warren and Darnell laboratories have identiﬁed ligands by
co-immunoprecipitation followed by microarray analysis,
complemented by extraction of polyribosomal fractions
(Brown et al. 2001). They discovered that FMRP and one of
its three RNA-binding domains speciﬁcally binds to G-rich
quartet motifs (Brown et al. 2001; Darnell et al. 2001; Denman
2003; Miyashiro et al. 2003). Three more studies found that
mRNAs containing U-rich motifs bind recombinant FMRP in
vitro and associate with FMRP-containing mRNPs in vivo
(Chen et al. 2003; Denman 2003). Lastly, antibody-positioned
RNA ampliﬁcation as a primary screen followed by tradi-
tional methods identiﬁed over 80 FMRP-regulated mRNAs,
with a combination of G-quartet and U-rich motifs in their
mRNA sequences (Miyashiro et al. 2003).
Independently, FMRP has been shown to be associated with
RISC components and miRNAs (Jin et al. 2004). The Drosophila
homolog of FMRP (FXR) and the Vasa intronic gene were
identiﬁed as components of RISC (Caudy et al. 2002). More
recent studies have proved that mammalian FMRP interacts
with miRNAs and with the components of the miRNA
pathways including Dicer and the mammalian orthologs of
Argonaute (AGO) 1 (Ishizuka et al. 2002; Jin et al. 2004). Given
the association of FMRP with Argonaute-containing com-
plexes, we propose and investigate the hypothesis that the
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derive hypotheses of speciﬁc pairing interactions.
Here, we predict miRNA targets in ﬁve vertebrate genomes
as a way of facilitating experiments and exploring a number
of open questions. What proportion of all genes is regulated
by miRNAs? How many genes are regulated by each miRNA?
Are speciﬁc cellular processes targeted by speciﬁc miRNAs or
by miRNAs in general? What is the extent of cooperativity in
miRNA:mRNA binding?
Results
Prediction of miRNA Targets
Using currently known mammalian miRNA sequences, we
scanned 39 untranslated regions (UTRs) from the human
(Homo sapiens), mouse (Mus musculus), and rat (Rattus norvegicus)
genomes for potential target sites. The scanning algorithm
was based on sequence complementarity between the mature
miRNA and the target site, binding energy of the miRNA–
target duplex, and evolutionary conservation of the target
site sequence and target position in aligned UTRs of
homologous genes. We identiﬁed as conserved across
mammals a total of 2,273 target genes with more than one
target site at 90% conservation of target site sequence (Tables
S2 and S3) and 660 target genes at 100% conservation. We
also scanned the zebraﬁsh (Danio rerio) and fugu (Fugu rubripes)
ﬁsh genomes for potential targets using known and predicted
miRNAs (Figure 1; Tables S4 and S5) and identiﬁed 1,578
target genes with two or more conserved miRNA sites
between the two ﬁsh species.
In addition to the analysis of 39 UTRs, we also scanned all
protein-coding regions for high-scoring miRNA target sites.
For convenience, these results are reported both as hits in
cDNAs (coding plus noncoding; Table S6) and as hits in
coding regions (Table S7), with cross-references in the UTR
target tables (number of hits in the coding region for each
UTR in Tables S2 and S3).
The algorithm and cutoff parameters were chosen to
provide a ﬂexible mechanism for position-speciﬁc constraints
and to capture what is currently known about experimentally
veriﬁed miRNA target sites: (1) nonuniform distribution of
the number of sequence-complementary target sites for
different miRNAs; (2) 59–39 asymmetry (the complementary
pairing of about ten nucleotides at the 59 end is more
important than that of the ten nucleotides at the 39 end
[Doench and Sharp 2004], and the matches near the 39 end
can to a limited extent compensate for weaker 59 binding);
and (3) inﬂuence of G:U wobbles on binding (Doench and
Sharp 2004). In choosing these parameters, we drew on
experience from careful analysis of target predictions in
Drosophila (Enright et al. 2003) as well as proposed human
targets of virus-encoded miRNAs (Pfeffer et al. 2004).
To facilitate evaluation of predicted targets and design of
new experiments, we provide methods and results in a
convenient and transparent form. We make the miRanda
software freely available under an open-source license, so that
researchers can adjust the algorithm, numerical parameters,
and position-speciﬁc rules. We also provide web resources,
including a viewer for browsing potential target sites,
conserved with or without positional constraints, on aligned
UTRs, with periodic updates (www.microrna.org), as well as
links to these targets from the miRNA registry site RFAM
(www.sanger.ac.uk; Grifﬁths-Jones 2004). We provide both
high-scoring targets, as strong candidates for validation
experiments, and lower-scoring targets, which may have a
role in broader background regulation of protein dose.
Expression information (see Table S3) for miRNAs and
mRNAs provides an additional ﬁlter for validation experi-
ments, in addition ranking target sites by complementarity
and evolutionary conservation.
Validation of Target Predictions
Only a small number of target sites of target genes
regulated by miRNAs have been experimentally veriﬁed, so
we sought direct and indirect evidence to help validate or
invalidate the proposed set of mammalian targets. (1) We
compared predicted targets with experimentally veriﬁed
targets in mammals, C. elegans, and D. melanogaster, as well as
their mammalian homologs. (2) We compared predicted
target numbers from real and shufﬂed miRNA sequences and
estimated the rate of false-positive predictions. (3) We
assessed the enrichment of miRNA targets in mRNAs that
Figure 1. Target Prediction Pipeline for miRNA Targets in Vertebrates
The mammalian (human, mouse, and rat) and ﬁsh (zebra and fugu) 39
UTRs were ﬁrst scanned for miRNA target sites using position-
speciﬁc rules of sequence complementarity. Next, aligned UTRs of
orthologous genes were used to check for conservation of miRNA–
target relationships (‘‘target conservation’’) between mammalian
genomes and, separately, between ﬁsh genomes. The main results
(bottom) are the conserved mammalian and conserved ﬁsh targets,
for each miRNA, as well as a smaller set of super-conserved vertebrate
targets.
DOI: 10.1371/journal.pbio.0020363.g001
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to be involved in translational regulation.
Agreement with known targets. We previously used known
miRNA sites for the let-7 and lin-4 miRNAs in Drosophila to
develop the target prediction method and check for
consistency (Enright et al. 2003). More recent experimental
target identiﬁcation provides independent control data.
Recent work in C. elegans (Vella et al. 2004) has narrowed
the originally reported list of six target sites for let-7 in the
UTR of lin-41 down to three elements, two target sites, and a
27-nt intervening sequence (a possible binding site for
another factor). The surviving two target sites have high
alignment scores, S = 115 and S = 110, while the other four
sites are below threshold (Enright et al. 2003), fully consistent
with the experimental results. As one of the conﬁrmed sites
has a single-residue bulge, target prediction methods that
require a perfect run of base pairs near the 59 end of the
miRNA would not detect it, while our method does. lsy-6, a
recently experimentally identiﬁed miRNA in C. elegans,
controls left–right neuronal asymmetry via cog-1, an Nkx-type
homeobox gene; the cog-1 gene has a target site in its 39 UTR,
which also has a high score (S = 125) and passes the
conservation ﬁlter.
Experiments in D. melanogaster have identiﬁed six new
miRNA–target gene pairs: miR-7 targets the notch signaling
genes HLHm3, HLHm4, and hairy, and miR-2b targets the genes
reaper, grim, and sickle (Stark et al. 2003). Consistent with these
experiments, our target predictions in D. melanogaster (Enright
et al. 2003) ranked HLHm3, hairy, and HLHm4 at positions 1, 3,
and 7, respectively, in the list of 143 target genes for miR-7
(Enright et al. 2003). Similarly, our predictions ranked reaper,
grim, and sickle at positions 3, 11, and 19, respectively, among
the other 120 predicted target genes for miR-2c. We also
predicted miR-6 to target this group of pro-apoptotic genes,
with sites that have lower scores than the miR-2 family but are
conserved in D. pseudoobscura. Unfortunately, one cannot in
general use these predicted and then validated target sites
(Stark et al. 2003) for the derivation of new prediction rules,
as the set of targets tested is limited to the type predicted and
is not exhaustive.
Indirect validation comes from the prediction that
mammalian orthologs of some of the known miRNA targets
in C. elegans and D. melanogaster are miRNA targets. An
example is the proposed conservation of the miRNA–target
relationship lin-4:lin-28 (we use the notation miRNA:mRNA
for a miRNA–target pair), ﬁrst discovered in worm (Moss and
Tang 2003): we detect target sites in human lin-28 for the lin-4
miRNA homolog miR-125. We also conﬁrm the human analog
of a let-7:lin-28 relation predicted in C. elegans (Reinhart et al.
2000). In summary, the predicted target sites on human lin-28
are miR-125 (1 site), let-7b (2 sites; Moss and Tang 2003), miR-
98 (2 sites), and miR-351 (1 site). Another known lin-4 and let-7
target in C. elegans is lin-41. The human homolog of lin-41
(sequence provided by F. J. Slack, personal communication)
and another closely related gene (encoding Tripartite motif
protein 2) are predicted as high-ranking targets of let-7 and
miR-125 (the human homolog of lin-4) (see Tables S2 and S3).
Another known instance of miRNA target regulation in
worms is the regulation of cog-1 by the lsy-6 miRNA (Johnston
and Hobert 2003). Although there is no obvious homolog of
lsy-6 in mammals, the vertebrate homolog of the target gene
cog-1, nkx-6.1, is a conserved target for ﬁve different miRNAs
in our predictions (see Table S2).
The comparison of our results with known targets shows
that our method can detect most (but not all) known target
sites and target genes at reasonably high rank. However, given
the small number of experimentally veriﬁed miRNA–target
pairs, additional validation tests are desirable, such as
statistical tests using randomization of miRNA sequences to
estimate false positives.
Estimate of false positives. As a computational control of
the validity of the prediction method, one can perform a
statistical test that attempts to estimate the probability that a
predicted site is incorrect. Here, a ‘‘false positive’’ is a
predicted target site of a real miRNA on a real mRNA that
has passed all relevant thresholds but is incorrect in that it is
not biologically meaningful. The statement ‘‘not biologically
meaningful’’ is rarely clearly deﬁned, but can reasonably be
taken to mean that no functionally effective miRNA:mRNA
interaction occurs under conditions of co-expression at
physiological concentration, where ‘‘functionally effective’’
is deﬁned in terms of detectable changes of phenotypic
attributes.
Technically, an estimate of the false-positive rate can be
obtained by computing (directly or via randomization) the
background distribution of scores for biologically non-
meaningful miRNA target sites and then deriving the
probability that a non-meaningful target site passes all score
thresholds, i.e., for a single aggregate score, that the incorrect
site has a score T . Tc, where Tc is a ﬁxed threshold that may
be, in general, different for each miRNA. We chose to
estimate the background distribution using shufﬂed miRNAs
obtained by swapping randomly selected pairs of bases of
each given miRNA 1,000 times, keeping the nucleotide
composition constant. The shufﬂed miRNA sequences were
scanned against human, mouse, and rat 39 UTR sequences
exactly as for the prediction procedure for real miRNA
sequences. In the procedure, a miRNA:mRNA match site is
predicted to be a target site if it passes three thresholds, S .
Sc for match score, jDGj . jDGcj for free energy of duplex
formation, and C . Cc for conservation, where C reﬂects a
binary evaluation of orthology of mRNAs, similarity of
position of the site on the mRNA, and a threshold percentage
of conserved residues in the two mRNA target sites. Finally,
the predicted target sites for a set of shufﬂed miRNAs are
counted and then averaged over a total of ten randomized
runs. The percentage of false positives for target transcripts
with more than two, three, and four sites is 39%, 30%, and
24%, respectively, using a non-permissive conservation
threshold of 100% for target site sequences (Figure 2). In
addition, the false-positive rate for single sites with a score of
more than 110 is approximately 35%.
To provide a realistic estimate of false positives using
randomization, the distribution of scores from random trials
(‘‘random-false’’) should be similar to the distribution of
incorrect (non-meaningful) hits from real trials (‘‘real-false’’).
The difference between these two distributions is difﬁcult to
compute in principle, as very few validated correct predic-
tions are known at present. For human sequences, without
any conservation ﬁlter, we obtained a total of 2,538,431
predicted target sites for real miRNAs, and, for shufﬂed
miRNAs, on average, 2,033,701 (6 82,172) target sites—a
difference of 20%. This difference may be indicative of a
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calculated by the miRanda algorithm or may be due to
different polynucleotide compositions of shufﬂed miRNAs
compared to real miRNAs. Even if this difference represents a
real effect, by far the most predictive criterion for accurate
target detection is conservation of target sites across species,
and not alignment scores or energies (20% compared to a
factor of three, see Figure 2; Table S8). As a consequence, the
current set of predicted targets rests heavily on the criterion
of conservation of miRNA:mRNA match between different
species. We believe this to be essentially true for all currently
published target prediction methods.
Indirect experimental support: FMRP-associated mRNAs.
An excellent opportunity to test our target predictions comes
from experiments showing the association of mRNAs and
miRNAs with proteins involved in translational control, even
if these experiments do not provide information on speciﬁc
miRNA:mRNA pairings. In particular, FMRP, which may
regulate translation in neurons, not only associates with
hundreds of mRNAs (Brown et al. 2001; Chen et al. 2003;
Denman 2003; Miyashiro et al. 2003; Waggoner and Liebhab-
er 2003) and with miRNAs (Jin et al. 2004), but also associates
with components of the miRNA processing machinery, Dicer,
and the mammalian homologs of AGO1 and AGO2 (Jin et al.
2004). If all FMRP-bound mRNAs are regulated by miRNAs,
one should see a large enrichment of predicted targets among
such mRNAs. We tested this hypothesis with 397 FMRP-
associated mRNAs taken from a number of recent experi-
ments (Brown et al. 2001; Chen et al. 2003; Denman 2003;
Miyashiro et al. 2003; Waggoner and Liebhaber 2003).
Are FMRP-bound messages enriched in predicted targets?
Using ﬁve different datasets (Table S9), we predicted that
74% of FMRP-associated messages are miRNA target genes
(294 of 397 mRNAs). This corresponds to an enrichment
factor of about ﬁve compared to the 59 targets one would
expect from our analysis in a randomly chosen set of 397
mRNAs, where 59/397 equals 4,462/29,785 (4,462 predicted
mammalian target mRNAs pass the 90% conservation ﬁlter
for one or more sites per transcript out of a total of 29,785
transcripts). This suggests that in the 397 FMRP target genes,
59 should pass the ﬁlters. The enrichment factor does not
vary much with the cutoff parameters used in target
prediction (data not shown), but is subject to some
uncertainty because of potential false-positive predictions.
The enrichment of miRNA:FMRP interaction is consistent
with the hypothesis that translational control involving FMRP
protein is executed in a complex that involves one or more
miRNAs interacting with transcripts at speciﬁc sites. Note
that this analysis supports the validity of target gene
prediction, not the identity of the controlling miRNA or
the accuracy of speciﬁc sites.
An additional validation test involved FMRP cargoes that
had been identiﬁed in more than one study, using independ-
ent experimental methods. For example, the mRNAs of 14
genes (Brown et al. 2001) were overrepresented in both the
polyribosome fraction of mouse fragile X cells and in co-
immunoprecipitation with mouse brain mRNPs that contain
FMRP. Almost all of the 14 genes are predicted targets with
more than one conserved site (11 of 12 annotated UTRs;
Table S9). In some cases, expression data provide additional
support: postsynaptic density protein 95 (PSD95)–associated (SA-
PAP4), a neuron-speciﬁc protein, is regulated by many
miRNAs highly expressed in rat brain primary cortical
neurons (Kim et al. 2004).
In summary, the three validation approaches (retrospec-
tive, statistical, and indirect experimental) suggest that the
current version of the miRanda algorithm, in spite of clear
limitations, can predict true miRNA targets at reasonable
accuracy, provided that (1) the targets are detected as
conserved and (2) the gene contains more than one miRNA
target site or a single high-scoring site (S . 110, approx-
imately, including sites with almost perfect complementarity
suggestive of mRNA cleavage).
Overview of Mammalian miRNA Target Genes
More than 2,000 mammalian targets. We predicted 2,273
genes as targets with two or more miRNA target sites in their
39 UTRs conserved in mammals at 90% target site con-
Figure 2. Distribution of Transcripts with
Cooperativity of Target Sites and Estimated
Number of False Positives
Each bar reﬂects the number of human
transcripts with a given number of target
sites on their UTR. Estimated rate of
false positives (e.g., 39% for  2 targets) is
given by the number of target sites
predicted using shufﬂed miRNAs pro-
cessed in a way identical to real miRNAs,
including the use of interspecies con-
servation ﬁlter.
DOI: 10.1371/journal.pbio.0020363.g002
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approximately 9% of protein-coding genes to be under
miRNA regulation. In addition, we predicted another 2,128
genes with only one target site, but the false-positive rate for
these is signiﬁcantly higher (Figure 2). Of these, the top-
scoring 480 genes (S . 110) have an estimated false-positive
rate comparable to that of genes with multiple sites and thus
also are good candidates for experimental veriﬁcation. Some
of the genes with single sites may contain additional sites that
we cannot detect for a number of reasons, including
truncated UTRs. A signiﬁcant subset of the total number of
single-site target genes (7%) has near complementary single
sites. These near complementary sites may indicate cleavage,
for which additional sites may not be necessary. The targets
listed in Table 1 were selected for variety of function,
variation in number of sites, and varied extent of conserva-
tion (some are also conserved in ﬁsh). Somewhat surprisingly,
the number of predicted targets per miRNA varies greatly,
from zero (for seven miRNAs) to 268 (for let-7b), but the
distribution is nonuniform (mean = 7.1, standard deviation
= 4.7; Figure 3). This indicates a range of speciﬁcity for most
miRNAs and suggests that regulation of one message by one
miRNA is rare.
Functional analysis. We analyzed the distribution of func-
tional annotation for all targets of all miRNAs using Gene
Ontology (GO) terms (see Materials and Methods; Table S10)
and domain annotations from InterPro (Mulder et al. 2003).
The target genes reﬂected a broad range of biological
functions (Figure S1). The most enriched GO term was
‘‘ubiquitin-protein ligase activity,’’ with 3.3-fold enrichment
(Table S10). Since ubiquitination is a process controlling the
quantity of speciﬁc proteins in a cell at speciﬁc times, miRNA
Table 1. Selection of Predicted miRNA Targets
Target miRNA
Gene Identiﬁer Description ID
BNOP3L 104765 Bcl2/Adenovirus E1b protein-interacting protein-3-like
protein
miR-17
CASP2 106144 Caspase 2 precursor miR-181b, miR-199a
112577 Delta1 miR-17–5p, miR-363, miR-351
DICER1 100697 Endoribonuclease Dicer miR-107, let-7e
EIF4E 151247 Eukaryotic translation initiation factor 4E miR-17–5p, miR-206 miR-325, miR-23,
EIF4EBP3 131503 Eukaryotic translation initiation factor 4E binding protein 3 miR-136
EFNB2 125266 Ephrin B2 ligand miR-312, miR-217, miR-340
HES1
a 114315 Transcription factor HES-1 miR-30, miR-24
HOX-C8 037965 Hox-3A, Hox-3.1 miR-196, let-7b,c,d
HOX-D8 175879 HOX-D8 miR-196, miR-203, miR-143
HOX-B8 120068 HOX-B8 miR-196, miR-328, miR-101b
LAR 142949 Leukocyte-antigen-related protein miR-133, miR-341, miR-347
MACF1 127603 Microtubule–actin cross-linking factor 1 miR-130
MECP 169057 Methyl-CPG-binding protein 2 miR-199a, let-7, miR-295
MYCC 136997 C-myc let-7b,c, miR-187
MYCN 134323 N-myc proto-oncogene protein miR-17, miR-152, miR-30a
NOG 183691 Noggin precursor miR-152
NBPHOX 109132 Paired mesoderm homeobox protein 2b miR-7
PCTK2 59758 Serine/Threonine-protein kinase PCTAIRE-2 miR-18
PLXDC2 120594 Tumor endothelial marker 7–related precursor miR-211, miR-10a
PLXNB1 164050 Semaphorin receptor miR-130b, miR-138, miR-130b, miR-245, miR-245
SARA1 79332 COPII-associated small GTPase miR-106, miR-17–5p, miR-20, miR-203
SLC7A1 139514 CAT-1/High affinity cationic amino acid transporter miR-122a
SMARCD2 108604 Swi/Snf-related matrix-associated regulator of chromatin d2 miR-30b, miR-234, miR-206, miR-206
SOS2 100485 Son of sevenless protein homolog 2 miR-98, let-7i,7e, miR-103 miR-107, miR-134
ST7 004866 Suppression of tumorigenicity 7 isoform A miR-301, miR-302, miR-266, miR-151
UBE3A 114062 Ubiquitin-protein ligase E3a miR-184, miR-103 miR-140 miR-17_5p
USP46 109189 Ubiquitin-specific protease 46 miR-190
N.A. 128594 NAG14 protein miR-33, miR-150, miR-300, miR-99b, miR-231
N.A. 142864 PAI-1 mRNA-binding protein miR-30, miR-19a
Add ‘‘ENSG00000’’ to the beginning of the identifiers to derive Ensembl identifiers. All miRNA–target relationships shown here are conserved in mammals, i.e., homologous
miRNAs target transcripts of homologous genes at similar UTR positions with similar local sequence. Genes that are predicted to be targets in both mammals and fish are in
bold. Where the miRNA–target relationship is also conserved in non-mammalian vertebrates, the miRNA is in bold.
a Contains conserved CPE motif.
N.A., not available.
DOI: 10.1371/journal.pbio.0020363.t001
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increase protein levels. Other overrepresented functional
terms were ‘‘neurogenesis’’ (3.2-fold), ‘‘protein serine/threo-
nine kinase’’ (2.5-fold), and ‘‘protein-tyrosine kinase activity’’
(2.5-fold).
The four domains most overrepresented in predicted
targets relative to all genes were Homeobox domain, 5.3-fold;
KH domain, 4.0-fold; and Guanine-nucleotide dissociation stim-
ulator CDC25 domain, 3.4-fold (Figure S1; Table S10).
Interestingly, KH domains are RNA-binding domains found
in a wide range of proteins such as hnRNPk, FMR1, and
NOVA-1. In addition to the Homeobox domain, other DNA-
binding domains and domains associated with chromatin
regulation were also enriched, suggesting that miRNAs in
animals target the transcription machinery disproportion-
ately, as they do in plants. Another overrepresented domain
was semaphorins (3.0-fold). The semaphorins and plexins (sem-
aphorin receptors) are involved in axon guidance, angio-
genesis, cell migration, the immune system, and the adult
nervous system (Pasterkamp and Verhaagen 2001). Many
semaphorins and their receptors are predicted targets of
brain-expressed miRNAs (e.g., let-7c, miR-125b, miR-153, miR-
103, miR-323, miR-326, and miR-337). The plexins dimerize
with Neuropilin (NP1) to signal the Semaphorin ligand
attachment; neuropilin is a predicted high-ranking target of
let-7g and miR-130, both brain-expressed miRNAs. A signiﬁ-
cant proportion of ephrin receptors (seven out of ten genes)
and ephrin ligands (ﬁve out of seven genes) are predicted
targets. The family of ephrins is involved in boundary
formation, cell migration, axon guidance, synapse formation,
and angiogenesis, and the ephrin ligand, EphA2, which
contains a conserved cytoplasmic polyadenylation element
(CPE) motif, is considered to be under translational regu-
lation in axon growth cones (Steward and Schuman 2003).
Although many members of the ephrin family are predicted
targets of brain-expressed miRNAs, they appear to be
targeted by different miRNAs, consistent with differential
regulation. In Drosophila, both ephrin and EphR, closest to the
mammalian B class of the ephrin family, also are predicted
miRNA targets.
Do speciﬁc miRNAs target particular functional groups?
We analyzed each miRNA individually for GO term and
domain enrichment (Table S10). The targets of some miRNAs
were strongly enriched in certain categories, e.g., miR-105 in
‘‘small GTPase mediated signal transduction’’ (5-fold), miR-
208 in ‘‘transcription factor’’ (6-fold), and miR-7, which lies in
the intron of the hnRNPk (an RNA-binding protein) gene, in
‘‘RNA binding proteins.’’ Neuronal differentiation of embry-
onic carcinoma cells by retinoic acid in both mice and
humans is coupled to induction of let-7b, miR-30, miR-98, miR-
103, and miR-135 (Sempere et al. 2004), and their targets are
enriched in ‘‘neurogenesis’’ (3.5-fold). miR-124a and miR-125,
both highly and speciﬁcally expressed in brain, preferentially
target RNA-binding proteins. Thirty-one new miRNAs (miR-
322–miR-352) cloned from rat neuronal polyribosomes have a
large number of neuronal target genes and share many
targets, e.g., miR-352 and miR-327 target 5HT-2c, and miR-
340, -328, -326, -331, and -333 potentially target beta-catenin,
which is implicated in various stages of neural differentiation.
Two highly expressed miRNAs in the thymus, miR-181a and
miR-142–3p are key components of a molecular circuitry that
modulates hematopoietic lineage (Chen et al. 2004). Ectopic
expression of miR-181a causes a 2-fold increase in the cells of
the B cell lymphoid lineage. Some of our high-ranking targets
for miR-181a may provide clues for the mechanism of this
effect. Germ cell nuclear factor GCNF (NR6A1) (the second-
highest-ranked target for miR-181a) is expressed in the
thymus and bone marrow. miR-181a itself is encoded on the
antisense strand of an intron of GCNF. We also predict that
the gene Bcl11b, known to affect B cell growth, is a target of
miR-181a, ranking third, as well as Lim/homeobox protein
LHX9, recently found expressed in developing thymus
(Woodside et al. 2004).
Figure 3. Multiplicity and Cooperativity in miRNA–Target Interactions
One miRNA can target more than one gene (multiplicity) (A), and one
gene can be controlled by more than one miRNA (cooperativity) (B).
The distributions are based on ordered (ranked) lists and decay
approximately exponentially (approximate straight line in log-linear
plot).
(A) Some miRNAs appear to be very promiscuous (top left), with
hundreds of predicted targets, but most miRNAs control only a few
genes (bottom right).
(B) Some target genes appear to be subject to highly cooperative
control (top left), but most genes do not have more than four targets
sites (bottom right). Although speciﬁc values are likely to change with
reﬁnement of target prediction rules, the overall character of the
distribution may well be a biologically relevant feature reﬂecting
system properties of regulation by miRNAs.
DOI: 10.1371/journal.pbio.0020363.g003
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Human MicroRNA TargetsFMRP cargo mRNAs regulated by miRNAs. FMRP is
composed of several RNA-binding domains (two KH and
one RRG) that bind messages. The speciﬁc binding motifs for
FMRP on messages are incompletely known, but are thought
to include G-quartet patterns and/or U-rich sequences
(Dolzhanskaya et al. 2003; Ramos et al. 2003). We predicted
294 mRNAs known to be FMRP cargoes as miRNA targets (see
Table S9). The most reliable of these (Table 2) reﬂect high
conﬁdence in experimental identiﬁcation of FMRP associa-
tion or conservation of target site between mammals and ﬁsh.
Alzheimer’s disease amyloid protein. Amyloid precursor
protein (APP) is an FMRP-bound protein that is translation-
ally regulated. The APP transcript contains a 29-nt motif at
position 200 in the 39 UTR that is known to aid destabiliza-
tion of the APP mRNA in certain nutrient conditions and that
binds nucleolin, a protein associated with RNPs containing
FMRP (Rajagopalan and Malter 2000). In addition, there is an
81-nt sequence at position 630 in the APP 39 UTR that is
required for the TGFbeta-induced stabilization of the APP
mRNA (Amara et al. 1999). We predicted APP as a target, with
a total score of S = 708 with a minimum of eight miRNA
sites, including two let-7 top-ranking sites that are conserved
in human, mouse, and rat. One of the predicted miRNA
target sites in the APP UTR lies in the 81-nt region (Figure 4),
and another is within 30 nt of the motif at position 200.
Other APP-interacting proteins, APP-binding family B
member 1 (mir-9, miR-340, and miR-135b), APP-binding family
member 2 (let-7 and miR-218), and APP-binding family 2 (miR-
188 and miR-206) were also predicted targets, some of which
had near exact target site matches. In summary, the APP gene
appears to be subject to translational regulation by the
combinatorial control of a number of different miRNAs.
PSD95 and synaptic processes. PSD95 and similar scaffold-
ing molecules, link the NMDA receptor with intracellular
enzymes that mediate signaling; this process is involved in the
development and maintenance of synaptic function and
synaptic plasticity, and interference in this process is
implicated in schizophrenia and bipolar disorder (Beneyto
and Meador-Woodruff 2003). FMRP binds PSD95 and is
required for mGluR-dependent translation of PSD95 (Todd
et al. 2003). PSD95 is a high-ranking target of miR-125, miR-
135, miR-320, and miR-327, all of which are either exclusively
expressed in brain or enriched in brain tissue (Lagos-
Quintana et al. 2002; Krichevsky et al. 2003; Sempere et al.
2004). In particular, large transcript numbers of miR-125b are
found copuriﬁed with polyribosomes in rat neurons in (Kim
et al. 2004). PSD95 has one reported G-quartet in its 39 UTR
at position 648 (Todd et al. 2003), further suggesting it as an
in vivo FMRP target. We predicted an additional G-quartet
site at position 205–235 in the 39 UTR of PSD95. One of the
Table 2. Selected FMRP Cargoes Predicted as miRNA Targets
Target miRNA
Gene Reference
a ID Description ID
APP
b,c Denman 2003 142192 Amyloid beta A4 protein precursor let-7
d, miR-130, miR-214
BASP1
c Brown et al. 2001 176788 Neuronal axonal membrane protein NAP-22 miR-207, miR-18, miR-22
CACNA1D Chen et al. 2003 157388 Voltage-dependent L-type calcium channel
alpha-1D subunit
miR-291–5p
CIC
b,c Brown et al. 2001 079432 Capicua (Drosophila) homolog miR-202, miR-210, miR-292-as
CLTC Chen et al. 2003 141367 Clathrin heavy chain 1 miR-122a, miR-330
DDX5 Chen et al. 2003 108654 Probable RNA-dependent helicase P68 miR-1d, miR-147, miR-154, miR-33
DLG3
c,e Chen et al. 2003 082458 Presynaptic protein SAP102 miR-15b, miR-196, miR-326
DLG4
c Brown et al. 2001 132535 PSD95, presynaptic density protein miR-125a
d, miR-135, miR-324–3p
FACL3
b,c Brown et al. 2001 123983 Long-chain Acyl-CoA synthetase 3 let-7
d, miR-141, miR-98
FMR1
c Brown et al. 2001 102081 FMRP1 miR-194
d, miR-297
d, miR-326
FMR2 Chen et al. 2003 155966 FMRP2 miR-152
d
FXR1
b Denman 2003 114416 FMRP1 let-7
d, miR-199, miR-336
HNRPA2B
c Chen et al. 2003 122566 Heterogeneous nuclear ribonucleoproteins
A2/B1
miR-103
d, miR-143, miR-151
HTR1B
b Denman 2003 135312 5-hydroxytrypatmine 1B receptor miR-292-as, miR-25, miR-202, miR-183
HTR2C
c Denman 2003 147246 5-Hydroxytrypatmine 2C receptor let-7e, miR-352, miR-199-as, miR-9
MAP1B Brown et al. 2001 131711 Microtubule-associated protein 1B miR-325, miR-136
MAP4K4 Brown et al. 2001 071054 Mitogen-activated protein kinase 4 miR-29a
Mint homolog
b Brown et al. 2001 065526 Smart/HDAC1-associated repressor protein miR-203
SEMA3F Miyashiro et al. 2003 001617 Semaphorin 3F miR-182, miR-325
Transcripts for genes (Gene and ID) are described as FMRP cargoes in several studies (DR) and predicted here as targets of specific miRNAs (miRNA). Selected from a total of
294 such targets.
a Reference from which data was extracted.
b Homologous miRNA–mRNA pair conserved in fish.
c Additional miRNAs are predicted to target the gene (number in parentheses): APP (9), BASP1 (4), Capicua (2), DLG3 (7), and DLG4 (5).
d The miRNA has multiple target sites on the gene.
e The 39 UTR of the gene contains a CPE motif (Table S11).
DOI: 10.1371/journal.pbio.0020363.t002
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Human MicroRNA TargetsmiRNA (miR-125) target sites overlaps with the G-quartets,
raising the possibility that miRNAs directly compete with
FMRP to bind the message in this location. Likewise, NAP-22,
which has three miRNA target sites (see Table S9), has a miR-
207 target site that overlaps with a G-quartet (Darnell et al.
2001).
Other PSD95 family members are also involved in synaptic
processes, in particular, in the integration of NMDA signaling
in the synaptic membrane. All PSD95 family members in
mammals (also known as discs large 1–5), SAP90, and CamKII
are predicted miRNA targets (see Table S9), as well as mGluR,
the protein product of which is an agonist that induces the
rapid translation of PSD95 (Todd et al. 2003) and three
NMDA receptor subunits (see Table S9). These results suggest
that miRNAs may be involved in NMDA and glutamate
receptor signaling to coordinate and integrate information,
with speciﬁcity achieved through the combinatorial action of
different miRNAs.
Components of RNPs Regulated by miRNAs
FMRP-associated proteins. FMRP binds its own mRNA,
implying negative feedback if the binding inhibits FMRP
production (Ceman et al. 1999). The fact that miRNAs target
transcripts for FMRP and FMRP-binding proteins suggests
another negative feedback loop in which high levels of these
proteins inhibit their own production (depending, of course,
on the concentration of miRNAs and mRNAs) (Figure 4). The
genes for six FMRP-associated (not associated at the same
time) proteins, hnRNP A1, Pur-alpha, Pur-beta, Staufen,
AGO-2, and PABP, are predicted miRNA targets. This
indicates that FMRP-containing RNPs are under miRNA
regulation. FXR2, a gene similar to FMR1 is also a miRNA
target in human, mouse, rat, and ﬁsh. Details of the implied
feedback regulation and differential control of RNP action
remain to be determined.
RISC. Our data suggest that the RNAi–miRNA machinery
itself is under miRNA regulation; for example Dicer appears
Figure 4. Potential miRNA Target Sites in
the 39 UTRs of Selected Genes
Nucleotide sequence conservation be-
tween the 39 UTRs of human and the
closest mouse or rat orthologous genes is
averaged for each block of 40 base pairs
(long rectangles; white indicates 0%
identical nucleotides, black indicates
100% identical nucleotides, and grey
indicates intermediate values). The posi-
tions of target sites for speciﬁc miRNAs
(triangles above rectangles, with num-
bers indicating miR miRNAs, e.g. ‘‘130’’ is
‘‘mir-130’’) are, in general, distributed
nonuniformly. Sequence motifs other
than target sites (triangles below rectan-
gles) are mRNA stability elements (APP),
a G-quartet (DLG4), and an AU-rich
element (ELAVL1), representing possible
protein-binding sites. Detailed align-
ments between the miRNA and the
predicted target sites (arbitrary selec-
tion) illustrate, in general, stronger
match density at the 59 end of miRNAs
than at the 39 end, as required by the
algorithm and as observed in experimen-
tally validated targets. The nonconserved
nucleotides in the target sites are high-
lighted in red. Gene names map to the
following Ensembl identiﬁers (142192 is
ENSG00000142192, etc.): APP, 142192;
CPEB2, 137449; DLG4, 132535; EFNB1,
090776; EIF2c1, 092847; ELAVL1,
066044; EPHB1, 154928; EPHB3,
182580; FMR1, 102081; FMR2, 155966;
FXR1, 114416; FXR2, 129245; and PTEN,
171862.
DOI: 10.1371/journal.pbio.0020363.g004
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Human MicroRNA Targetsto be controlled by let-7 and miR-15b; Ago-1 by let-7 and miR-
29b/c; Ago-2 by miR-138; Ago-3 by miR-138, miR-25, and miR-
103; and Ago-4 by miR-27a/b. Dicer and two of the Argonautes
also are predicted to be targets in both zebraﬁsh and fugu.
The let-7 sites on the 39 UTR of Dicer and Ago-1 (Figure 4) will
accommodate most of the let-7 variants with similar scores.
The variants of let-7 are expressed in a wide range of tissues
and developmental stages, suggesting broad regulation of
Dicer and Ago-1 by miRNAs. In contrast, the only miRNA that
targets Ago-2 is miR-138, which has so far been cloned only
once in the cerebellum (Lagos-Quintana et al. 2002). The
target site for miR-138 has only one mismatch at position 8;
this may induce a siRNA-like cleavage of the message
(Hutva ´gner and Zamore 2002a; Doench et al. 2003). Ago-3 is
also a top target for miR-138, with only two mismatches in its
site. We suggest that some miRNAs targeting this machinery
(e.g., let-7, miR-27, miR-29, and miR-103) are expressed fairly
widely, while others (e.g., miR-138 and miR-25) have lower and
more restricted expression.
Other RNPs. The highly conserved RNA-binding proteins,
ELAV-like proteins (HuR, HuB, HuC, and HuD), contain
three RNA-recognition motifs, which bind AU-rich elements
in 39 UTRs of a subset of target mRNAs (Good 1995). These
AU-rich elements increase the proteins’ cytoplasmic stability
and increase translatability (Perrone-Bizzozero and Bologna-
ni 2002). Experiments have identiﬁed 18 mRNAs bound to
HuB in retinoic-acid-induced cells; of the 14 we were able to
map unambiguously, 12 are predicted miRNA target genes:
Elavl1 (known to regulate its own mRNA), Gap-43, c-fos, PN-1,
Krox-24, CD51, CF2R, CTCF, NF-M, GLUT-1, c-myc, and N-
cadherin (Tenenbaum et al. 2000). Three of the ELAV-like
genes themselves are also targets of a large number of
miRNAs (see Tables S2 and S3; Figure 4). This is yet another
example of miRNAs predicted to target the bound messages
of RNA-binding proteins and of the regulation of RNA-
binding genes by miRNAs.
Cytoplasmic Polyadenylation Binding Proteins Regulated
by miRNAs
We predicted all four human cytoplasmic polyadenylation
binding proteins (CPEBs) known in mammals as miRNA
targets ranked within the top 170 target genes with 6–20 sites
in their UTRs (Figure 4; Table S11). Indeed, CPEB2 is the
highest-ranking gene of all transcripts. The orthologs to
CPEB1 in ﬁsh and ﬂy (known as orb in D. melanogaster) are also
predicted as targets. CPEB is an RNA-binding protein ﬁrst
shown to activate translationally dormant mRNAs by regulat-
ing cytoplasmic polyadenylation in Xenopus oocytes (Hake
and Richter 1994). It also regulates dendritic synaptic
plasticity (Mendez and Richter 2001; Richter 2001) and
dendritic mRNA transport (Mendez and Richter 2001; Huang
et al. 2003) and facilitates transport of mRNAs in dendrites
together with kinesin and dynein in RNPs (Huang et al. 2003).
CPEB binds to its target message through the CPE motif
(UUUUAU), which must be within a certain distance of the
hexanucleotide AAUAAA. CPEB keeps messages in their
dormant state until phosphorylated, after which it activates
polyadenylation (Mendez et al. 2000), thereby activating
translation or degradation (Mendez et al. 2002). In addition,
CPEB co-fractionates with the postsynaptic density fraction
in mouse synaptosomes, consistent with translation of stored
mRNAs in dendrites being part of the mechanism of synaptic
plasticity. We have three more lines of evidence suggesting
the notion that translational regulation by CPEB is linked to
miRNA regulation. First, our target list and the list of genes
regulated by CPEB signiﬁcantly overlap. There are nine genes
known to be CPEB-regulated, seven of which are predicted
targets: alpha-CAMIIK, Map 2, Inositol 1, 4–5-Triphosphate
Receptor type 1, Ephrin A receptor class A type 2, SCP-1, and
CPEB3 (Mendez and Richter 2001). Second, CPEB is known to
self-regulate in D. melanogaster (Tan et al. 2001). The CPEB1
homolog in ﬂy, orb, and CPEBs in vertebrates are predicted
miRNA targets. Third, the gene most correlated in expression
to the CPEB homolog in D. melanogaster is a Piwi protein
(Sting), a member of the Argonaute family (Pal-Bhadra et al.
2002; Stuart et al. 2003) that is involved in translational
regulation and in the RISC.
Among the predicted miRNA targets, 115 genes also
contained CPE motifs, which were conserved in at least two
mammals in the same positions in the UTRs and are therefore
candidates for CPEB regulation (Table S11; see Materials and
Methods). Our predictions include HuB, HuR, Eif-4 gamma,
DAZ associated protein 2, VAMP-2 (known to be posttran-
scriptionally regulated), Presynaptic protein SAP102, and
brain-derived neurotrophic factor precursor. Taken together
these data suggest that the CPEB genes, the known CPEB-
regulated genes, and the predicted CPEB-regulated genes are
strong miRNA target candidates and provide rich ground for
experimentation.
Targets of Cancer-Related miRNAs
Deregulated expression of certain miRNAs has been linked
to human proliferative diseases such as B cell chronic
lymphocytic leukemia (Calin et al. 2002; Lagos-Quintana et
al. 2003) and colorectal neoplasia (Michael et al. 2003). Recent
analysis of the genomic location of known miRNA genes
suggested that 50% of miRNA genes are in cancer-associated
genomic regions or in fragile sites (Calin et al. 2004). The
miRNAs miR-15 and miR-16 are located within a 30-kb region
at Chromosome 13q14, a region deleted in 50% of B cell
chronic lymphocytic leukemias, 50% of mantle cell lympho-
mas, 16%–40% of multiple myelomas, and 60% of prostate
cancers (Calin et al. 2002). Furthermore, miR-15 and miR-16
are down-regulated, or their loci lost, in 68% of B cell chronic
lymphocytic leukemias (Calin et al. 2002). Similarly, miR-143
and miR-145 are down-regulated at the adenomatous and
cancer stages of colorectal neoplasia (Michael et al. 2003), and
miR-155 is up-regulated in children with Burkitt lymphoma
(Metzler et al. 2004).
Our method predicted cancer-speciﬁc (by annotation) gene
targets of miR-15a, miR-15b, miR-16, miR-143, miR-145, and
miR-155. The target genes and their miRNA regulators are as
follows: (1) CNOT7, a gene expressed in colorectal cell lines
and primary tumors (Flanagan et al. 2003) (miR-15a); (2)
LASS2, a tumor metastasis suppressor (Pan et al. 2001) (miR-
15b); (3) ING4, a homolog of the tumor suppressor p33 ING1b,
which stimulates cell cycle arrest, repair, and apoptosis
(Shiseki et al. 2003) (miR-143); (4) Gab1, encoding multivalent
Grb2-associated docking protein, which is involved in cell
proliferation and survival (Yart et al. 2003) (miR-155); and (5)
COL3A1, a gene up-regulated in advanced carcinoma (Tapper
et al. 2001) (miR-145).
miR-16 has a tantalizing number of high-ranking targets
that are cancer associated and speciﬁcally involved in the
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controls pathways important for the surveillance of genome
integrity (Muller et al. 2004). The ﬁrst- and ﬁfth-highest-
ranked targets of miR-16 are Sumo-1 activating and con-
jugating enzymes, respectively. The top two single-site targets
for miR-16 are an Activin type II receptor gene (TGFbeta
signaling) and Hox-A5, both known to be dysregulated at the
level of protein expression in colon cancers (Wang et al.
2001). Both of these sites show near perfect complementary
matching between miR-16 and the target genes (indicating
possible cleavage). Both of these target genes are also targets
for another cancer related miRNA, miR-15.
Targets Conserved between Mammals and Fish
Roughly 55 miRNAs have identical mature sequences in
fugu and mammals, and 80 have very similar sequences in the
two species; additional ﬁsh miRNA sequences can be
predicted with conﬁdence based on sequence similarity. It
is therefore reasonable to expect that the targets of these
probably functionally homologous miRNAs are orthologous
genes in the different species. To follow up on this hypothesis,
we assessed conservation of mammalian miRNA–target pairs
between the 2,273 mammalian and 1,578 ﬁsh miRNA targets
(with more than one target site per UTR). The analysis yielded
240 target genes conserved between mammals and ﬁsh. The
number 240 is probably an underestimate because of several
factors, including: (1) unﬁnished annotation of genomes,
particularly rat and fugu; (2) ambiguity in assigning orthologs;
and (3) lack of UTR information.
The full set of conserved target genes between ﬁsh and
mammals indicates a wide functional range of conserved
targets (Table S12). Many Hox genes are conserved as targets,
including the miR-196 targets, Hox-A4:miR-34a, Hox-C9:let-7b
(near prefect complementary match), and Hox-B5:miR-27b.
Examples from the notch signaling pathway include miR-
30:hairy enhancer of split 1 (Hes1) and miR-152:noggin.
Targets Conserved between Vertebrates and Flies
Twenty-eight of the 78 identiﬁed miRNAs in ﬂies have
apparent mammalian homologs. Based on this remarkable
conservation across hundreds of millions of years, it is
reasonable to expect that there is some conservation of
target sites, target genes, and target pathways between ﬂies
and humans. Most strikingly we can identify hox genes and
axon guidance genes as common targets between vertebrates
and ﬂies, e.g., capicua and sex combs reduced (one of the
vertebrate homologs of Hox-A5). The hox gene cluster in
Drosophila contains high-ranking predicted targets (Enright et
al. 2003) of miR-10 and miR-iab-4, and the hox gene cluster in
mammals contains high-ranking targets of miR-196. These
miRNAs are themselves located in the hox gene region. We
predicted miR-iab-4–3p to target abd-B in Drosophila, a gene
related to the ancestral hox-7 cluster, the ancestral parent of
many of the predicted targets of miR-196. Axon guidance
receptors and ligands conserved as targets include Lar,
ephrins, and slits. Human slit1 is a top target of miR-218,
which itself is transcribed from the intron of slit2, suggesting
down-regulation of slit1 by transcription of slit2. We expect
that there are many more conserved targets but we are
hindered by the difﬁculty of mapping orthologous genes
between human and ﬁsh. Future work will elucidate to what
extent there are common pathways regulated by common
miRNAs between vertebrates and invertebrates.
Target Sites in Protein-Coding Sequences
Experiments suggest that miRNA target sites in metazoans
are preferentially in UTRs, not in coding regions. If this is
true, a correct target site prediction method should predict a
larger number of targets in UTRs than in coding regions.
Alternatively, target sites in coding regions may so far have
escaped experimental veriﬁcation, especially in plants, in
which targets of miRNAs in coding regions are the rule, not
the exception.
To investigate this issue we computed the average density
of target sites for high-scoring targets (S . 130) and before
application of conservation ﬁlters. The statistical assessment
of the inﬂuence of conservation ﬁlters in coding regions
would have raised complicated issues, as nearly two-thirds of
nucleotides in coding regions are conserved between mam-
malian genomes to preserve amino acid sequences. Interest-
ingly, we found, on average, 11 pre-conservation target sites
per 1 million nucleotides in coding regions, versus 15 such
target sites per 1 million nucleotides in UTRs. This is
consistent with a stronger ‘‘raw’’ prediction signal in UTRs
and may indicate a lower number of biologically relevant
target sites in coding regions in mammals, consistent with
early experimental ﬁndings.
As a guide to experimentation, we report all sites in coding
regions with an alignment score above 110 for miRNAs of
length up to 20 nt and an alignment score above 130 for
miRNAs longer than 20 nt (scores depend on the length).
These cutoff scores approximately correspond to a 75%
complementary match between miRNA and target, leaving
open the question of how many match pairs are needed to
lead to translational inhibition in coding regions, by any
mechanism. We identiﬁed 942 genes that contained such sites
in their coding regions. Strikingly, there was only one site
with a perfect match, and this was for the imprinted miR-127,
known to be antisense to the reciprocally imprinted retro-
transposon-like gene on the opposite strand (Seitz et al.
2003). Of the 942 genes, 25% have been otherwise identiﬁed
as targets based on conserved target sites in their UTRs.
However, only ﬁve genes have targets sites in their UTRs
complementary to the same miRNA that targets the coding
region (see Table S3, columns H and I). For example, miR-211
has a near perfect complementary site in the coding region of
a gene of unknown function (Ensembl ID ENSG00000134030,
containing an Eif-4 gamma domain) and also has two
conserved ‘‘normal’’ sites in the UTR. Similarly, miR-198 has
a site in the coding region, as well as conserved sites in the
UTR region, of a sodium and chloride GABA transporter
(Ensembl ID ENSG00000157103). However, we see no trend
for miRNAs that have conserved sites in UTRs to have
additional sites in the coding region; rather, stronger target
sites for a given miRNA tend to be conﬁned either to the UTR
or the coding region and are rarely in both.
Target Sites with Near Perfect Matches in cDNAs
We scanned all cDNAs for high-scoring matches without
using conservation to check for high-scoring targets, which
we may have missed through strict conservation rules (see
Table S6). Over 40 genes contain sites that have near perfect
complementarity to a miRNA (S .120), and these target
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in the case of miR-196 and Hox-B8. For example miR-298, an
embryonic-stem-cell-speciﬁc miRNA (Houbaviy et al. 2003),
has a near match with MCL-1, and miR-328 (neuronally
expressed) has a near match with LIMK-1, which is known to
be involved in synapse formation and function. miR-129,
expressed in mouse cerebellum, has a near perfect comple-
mentary match with Musashi-1, which is an RNA-binding gene
essential for neural development, regulated in the cerebel-
lum, and up-regulated in medulloblastoma (Yokota et al.
2004).
Comparison of miRNA Target Prediction Methods
Recently, several computational methods for the predic-
tion of miRNA targets have been developed (Enright et al.
2003; Lewis et al. 2003; Rajewsky and Socci 2003; Stark et al.
2003; Kiriakidou et al. 2004; Rehmsmeier et al. 2004). Two of
these have been applied to mammalian miRNAs, as described
in Lewis et al. (2003) and Kiriakidou et al. (2004). We now
compare and contrast these two methods with each other and
with the current version of our method, as further developed
from miRanda 1.0 and as applied to mammalian and
vertebrate genomes (Enright et al. 2003). We compare
algorithms and target lists, as an aid to the design of
experiments.
The three prediction methods share the goal of identifying
mRNAs targeted by miRNAs. All three use sequence
complementarity, free energy calculations of duplex forma-
tion, and evolutionary arguments in developing a scoring
scheme for evaluation of potential targets. Results are
reported as lists of target sites and lists of target genes
containing such sites. The three methods differ, however, in
important technical details, such as the datasets of miRNA
and UTR sequences and the algorithm and scoring scheme, as
well as the report format. We now summarize these technical
differences and compare the lists of resulting target genes for
a common subset of miRNAs. The interpretation of such
comparisons is hampered by the fact that selection criteria
and the use of numerical cutoffs differ conceptually, and
genomic coverage is nonuniform.
In the ﬁrst method, Lewis et al. used 79 miRNAs in human,
mouse, and rat, seeking targets in a UTR dataset extracted
from the June 2003 version of the Ensembl database. The
UTR dataset had 14,300 ortholog triplets conserved between
human, mouse, and rat and 17,000 ortholog pairs between
human and mouse. All annotated UTRs were extended by 2
kb of 39 ﬂanking sequence. The algorithm required exact
complementarity of a 7-nt miRNA ‘‘seed’’ sequence, deﬁned
as positions 2–8 from the 59 end of the miRNA, to a potential
target site on the mRNA, followed by optimization of mRNA–
miRNA duplex free energies between an extended window of
35 additional bases of the mRNA and the rest of the miRNA.
Target genes were ranked using a composite scoring function,
which took into account all sites for a particular miRNA on a
given mRNA. Conserved miRNA:mRNA pairs were required
to involve orthologs of miRNA and mRNA in human, mouse,
and rat, but there was no requirement for conservation of
target site sequence (beyond the seed match) or position on
the mRNA. Using shufﬂed miRNA sequences, with the
constraint that shufﬂed controls match real miRNAs in
relevant sequence properties, the false-positive rate of
predictions was estimated to be 50% for target genes
conserved between mouse and human, 31% for target genes
conserved in human, mouse, and rat, and 22% for target
genes identiﬁed in fugu as well as mammals. As a ﬁnal result,
Lewis et al. reported 400 conserved target genes for the 79
miRNAs. Among these targets, 107 genes were reported as
conserved in the ﬁsh fugu.
In the second method, Kiriakidou et al. used 94 miRNAs in
human and mouse, seeking targets in a dataset of 13,000
UTRs conserved in mouse and human (from Ensembl, date
not given). The algorithm used a 38-nt sliding mRNA window
and calculation of miRNA–mRNA duplex free energies,
keeping duplexes with energies below  20 kcal/mol. The
duplexes were further ﬁltered using a set of requirements
regarding matches and loop lengths in certain positions, as
derived and extrapolated from experimental tests involving a
predicted target site for let-7b miRNA on the UTR of the
human homolog of worm lin-28. The target site sequence was
engineered into a Luciferase reporter, followed by sequence
variation of the target site and test of an initial set of 15
predictions in the same reporter assay. Using shufﬂed miRNA
sequences, and applying the same rules and parameters, the
false-positive rate of predictions was estimated to be 50% for
targets conserved between human and mouse. As a ﬁnal
result, Kiriakidou et al. reported 5,031 human targets, with
222 reported as conserved in the mouse.
In the third method (this work), we used 218 mammalian
miRNAs and 29,785 transcripts derived from Ensembl (Table
3) and, as a ﬁnal result, report 4,467 target genes. What are
the main differences between these three prediction meth-
ods? Comparison of the total number of predicted target
genes is not very informative, as different datasets and cutoffs
were used. We attempted to remove one of the technical
Table 3. Number of Genes and 39 UTR Sequences Used for Target Prediction 39
Organism Ensembl Build Total Genes Total Transcripts Ensembl 39 UTRs Predicted 39 UTRs
Human 19_34b 23,531 29,785 20,579 9,206
Mouse 19_32 25,329 31,387 19,496 11,891
Rat 19_3b 23,751 28,251 4,339 23,912
Zebrafish 17_2 20,036 24,469 3,495 20,974
Fugu 17_2 35,180 37,539 653 36,886
DOI: 10.1371/journal.pbio.0020363.t003
PLoS Biology | www.plosbiology.org November 2004 | Volume 2 | Issue 11 | e363 1873
Human MicroRNA Targetsdifferences, by explicitly comparing reported targets for the
same set of 79 miRNAs used by Lewis et al. (although
signiﬁcant differences remained in the sets of UTR sequences
used): the overlap of target genes between Kiriakidou et al.
(out of 189) and Lewis et al. (out of 400) was 10.6%; the
overlap between Lewis et al. (out of 400) and this work (out of
2,673) was 46%; and the overlap between Kiriakidou et al.
(out of 189) and this work (out of 2,673) was 49%. In each case
the totals (‘‘out of’’) are the number of target genes for the
common set of 79 miRNAs and the percentage is relative to
the smaller set of two compared. The obvious reason for the
larger overlap with our results, 46% and 49% respectively, is
the larger number of targets in our predictions, which in turn
is primarily the result of choice of cutoff.
Direct comparison of the three prediction methods is
complicated by the fact that the noticeable differences
between the target lists of the three methods are due to the
aggregate effects of datasets, algorithm, including selection
rules, use of conservation, and cutoffs. The following
characteristics of the three methods underlie these differ-
ences and should be taken into consideration when choosing
targets for experimentation. (1) As to UTR datasets, Lewis et
al., with the earliest published report, used a smaller set of
UTRs, with some likelihood of false positives as a result of
UTR extension. The UTR sets used in this work, the third in
terms of publication date, are the most comprehensive and
plausibly the most reliable (as of February 2004). (2) As to
miRNA datasets, there was an increase from 79 for Lewis et al.
to 94 for Kiriakidou et al. to 218 miRNAs used in this work.
(3) As to the cooperativity of binding, the scoring system of
Lewis et al. evaluated cooperativity of multiple target sites by
the same miRNA on a target gene, but disregarded multiple
target sites from different miRNAs on one gene; that of
Kiriakidou et al. focused on single sites; and that of this work
gave high scores to multiple hits on a target gene, no matter
whether these hits involved the same miRNA or different
miRNAs. These tendencies are not exclusive where scores
involve functions of several real numbers, with cutoffs
applied to the aggregate score; e.g., our method also allows
strong single target sites. (4) As to assessment of false positives
using statistical methods based on shufﬂing, the comparison
of percentages is inconclusive, as the statistics of the
background distribution of true negatives is not well known.
It appears certain, however, from both Lewis et al. and this
work, that statistical conﬁdence increases with the extent of
conservation among increasingly distant species. (5) As to
validation experiments, each of the methods used a different
type and set, with mixed overall conclusions. On the
reassuring side, there was direct validation of some of the
predicted target sites of Lewis et al. and of Kiriakidou et al.
using reporter constructs in cell lines. We found some
agreement between the sites validated in this way and our
predicted targets (details in Table S13), but in some cases we
predicted different details of target sites for a given
experimentally tested miRNA:mRNA pair. Also, Kiriakidou
et al. used a series of such experiments to extrapolate from a
set of speciﬁc sequence variants to general rules for
identiﬁcation of target sites. However, serious doubts about
the validity of any set of rules persist as there is very little in
vivo validation in which native levels of speciﬁc miRNAs are
shown to interact with identiﬁed native mRNA targets with
observable phenotypic consequences under normal physio-
logical conditions. (6) As to differences in algorithm, one can
state opinions about the strengths or weaknesses of each
particular algorithm, but the relationship between each
prediction method and the actual in vivo process by which
miRNAs have functional interactions with their target
mRNAs remains unclear or, at best, unproven. In summary,
in our view, each of the three methods, including the one in
this work, falls substantially short of capturing the full detail
of physical, temporal, and spatial requirements of biologically
signiﬁcant miRNA–mRNA interaction. As such, the target
lists remain largely unproven, but useful hypotheses.
The predicted targets are useful in practice for the design
of experiments as they increase the efﬁciency of validation
experiments by focusing on target lists signiﬁcantly enhanced
in likely targets, compared to random. It is plausible that
targets near the top of lists are the most likely to lead to
successful experiments. Task-speciﬁc ﬁltering of target lists
for particular planned experiments is recommended, espe-
cially with respect to cooperativity of binding (more than one
site for one or more miRNAs on one gene transcript) and
coincidence of expression, as new data on expression
patterns of miRNAs and mRNAs in different tissues become
available. For example, a recommended conservative ap-
proach to the design of experiments would use all available
expression information and restrict the predicted target
genes to those with two or more target sites at normal
threshold (S . 90) or one target site with a higher threshold (S
. 110), counting only sites with up to one G:U pair in
residues 2–8 counting from the 59 end of the miRNA.
To take into account the rapid development of this ﬁeld
and the likely close interaction of theory and experiment, we
plan to periodically update our prediction method and
parameters and make revised target lists available on
www.microrna.org. Next, we discuss some conceptual con-
sequences of the composition of our target list.
Discussion
How Widespread Is the Regulation of Translation by
miRNA?
With plausible parameters, we have predicted that close to
9% (2,273 out of 23,531) of all mammalian genes have more
than one miRNA target site in their 39 UTRs, with 1,314 being
stronger candidates with more than two target sites. This
could well be an underestimate of the total number of genes
subject to miRNA regulation, as we have used a conservative
conservation ﬁlter. On the other hand, not all predicted
miRNA–mRNA pairs would have a biological consequence
unless both miRNA and mRNA are expressed at the same
time in the same cell and at sufﬁcient concentration. The
human genome has about 250 miRNA genes, compared to
about 35,000 protein genes. Thus, the the determination that
about 1% of genes (miRNAs) control the expression of more
than 10% of genes is a reasonable ﬁrst order estimate. It is
currently not known if any miRNAs control the expression of
miRNA genes, i.e., the progression from miRNA transcript to
mature miRNA.
How Conserved in Evolution Are miRNA Targets?
As many miRNA sequences are detectably conserved across
large evolutionary distances, they must be subject to strong
functional constraints. These constraints are unlikely to come
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tally validated animal miRNAs rarely have perfectly matched
target sites. Plausibly, the evolution of miRNAs is constrained
by functional interactions with multiple targets. As a
consequence, any compensatory mutation in the miRNA in
response to mutations in a target site would be disruptive to
the miRNA’s interaction with other target sites. Co-evolution
of the miRNA sequence and all of its target sequences is
therefore a rare event. With these assumptions, the con-
straints on the local mRNA sequence of individual target sites
are weaker than those on the miRNA sequence. We were
therefore surprised to observe a substantial number of cases
(28.6% of the 2,273 targets) with 100% conservation of target
site sequence and with the target sites being within ten
nucleotides of each other on the globally aligned UTRs of
orthologous genes between mammals.
Lacking more detailed knowledge of miRNA evolution, we
draw two operational conclusions. (1) Conservation of target
site sequence and position is a practical information ﬁlter for
predicted target sites, reducing the rate of false positives. (2)
It is very likely that new miRNAs have continuously appeared
in evolution (Lai 2003) at some non-negligible rate and that
the set of targets for any given miRNA has lost or gained
members, even between species as close as human and mouse.
It is therefore important to develop prediction tools that do
not rely on conservation ﬁlters or at least allow us to make
them weaker. Work on this is in progress.
Multiplicity and Cooperativity
Regulation by miRNAs is obviously not as simple as one
miRNA–one target gene, as perhaps the early examples (lin-4
and let-7) seemed to indicate. The distribution of predicted
targets reﬂects more complicated combinatorics, both in
terms of target multiplicity (more than one target per
miRNA) and signal integration (more than one miRNA per
target gene).
The distribution of the number of target genes (and target
sites) per miRNA is highly nonuniform, ranging from zero for
seven miRNAs to 268 for let-7b, with an average of 7.1 targets
per miRNA. It is difﬁcult to describe in detail, beyond the
examples discussed in this text and beyond the annotation of
target genes in Figure 2 and Table S3, which speciﬁc
processes appear to be regulated by each miRNA or each
set of co-expressed miRNAs. Groups of targets may reﬂect a
reaction, a pathway, or a functional class (see Results).
Although all miRNA–target pairs are subject to the condition
of synchrony of expression, it is likely that typically one
miRNA regulates the translation of a number of target
messages and that, in some cases, the target genes as a group
are involved in a particular cellular process. This was already
known for the case of lin-4 (Ambros 2003).
The number of miRNA target sites per gene is also
nonuniform, with a mean of 2.4. Although we do list target
genes with single miRNA sites, there is increasing evidence
that, in general, two or more sites are needed in the context
of repression of translation. Although the details of these
distributions (see Figure 2 and Table S3) depend on technical
details, such as uniform cutoff for all miRNAs and evaluation
in terms of a particular, imperfect scoring system, the general
features of the distributions (see Figure 3) may be generally
valid.
We conclude that multiplicity of targets and cooperative
signal integration on target genes are key features of the
control of translation by miRNAs. Neither multiplicity nor
cooperativity is a novel feature in the regulation of gene
expression. Indeed, regulation by transcription factors
appears to be characterized, at least in eukaryotes, by
analogous one-to-many and many-to-one relations between
regulating factor and regulated genes (Kadonaga 2004). We
are, of course, aware that the control cycles and feedback
loops involving miRNAs cannot be adequately described
without more detailed knowledge of the control of tran-
scription of miRNA genes, about which little is known at
present.
Mechanisms of miRNA Action
The role of a few animal miRNAs as posttranscriptional
regulators of gene expression and, in particular, as inhibitors
of translation is well established. However, the molecular
mechanism of action is not well understood. Posttranscrip-
tional control of protein levels can be achieved, for example,
by cleaving the mRNA, by preventing RNP transport to
ribosomes, by stalling or otherwise inhibiting translation on
ribosomes, or by facilitating the formation of protein
complexes near ribosomes that degrade nascent polypeptide
chains. What do our results imply regarding the mechanism
of action?
In analogy to plant miRNAs that have near perfect
sequence complementarity and facilitate mRNA degradation,
our predicted targets with near perfect complementarity
between miRNA and mRNA plausibly are involved in mRNA
cleavage (e.g., miR-196 and miR-138; see Results). Most of these
would involve single target sites. In the case of Hox-B8,
cleavage has been experimentally shown in mammalian cells
(Yekta et al. 2004). We estimate that fewer than 5% of miRNA
targets are cleaved as a result of miRNA binding.
Multiple target sites of lesser complementarity are con-
sistent with RNP formation leading to translational inhi-
bition, not mRNA degradation. Although we did predict
single miRNA target sites for some genes, most target genes
have multiple sites, indicating that cooperative binding
(Doench and Sharp 2004) may be essential for formation of
inhibitory RNP complexes.
An interesting and somewhat paradoxical feature is seen
with mRNAs bound by FMRP, some of which increased and
some of which are decreased in polysome fractions in FMRP
knock-out mice (Brown et al. 2001). We see no bias in which
of these two sets is most enhanced as predicted miRNA
targets. This ambiguity not only raises questions about details
of FMRP regulation but also raises the possibility that miRNA
targets may not always be translationally repressed and may
instead be translationally enhanced.
Improvement of Prediction Rules
Current methods for predicting miRNA targets rely on
conservation ﬁlters to reduce noise. Although the miRNA–
mRNA pairings of experimentally validated targets were
carefully used to deﬁne prediction rules (Enright et al. 2003;
Lewis et al. 2003; Stark et al. 2003), the information content in
sequence match scores and free energy estimates of RNA
duplex formation appears to be low. What is missing? Perhaps
the ﬁne details of experimentally proven target site matches
are incorrect, although in some experiments mismatches and
insertions have been tested. More plausibly, the rules do not
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miRNAs, such as in maturation and transport. Such addi-
tional interactions remain to be described in molecular
detail, such as interactions with the small RNA processing
machinery (Drosha and Dicer) and with the components of
RNPs (AGO and FMRP). A ﬁrst step in this direction is the
very recent analysis of the crystal structure of a PAZ domain
of a human Argonaute protein, eIF2c1, complexed with a 9-
mer RNA oligonucleotide in dimer conﬁguration, which may
represent three-dimensional interactions for the 39 end of a
miRNA (and siRNA) complexed, e.g., with Dicer or AGO (Ma
et al. 2004). In this structure, each PAZ domain makes close
binding contact with nine nucleotides of a single-stranded
RNA. The two 39 terminal nucleotides bind in a pocket
through RNA backbone and other contacts. The remaining
seven nucleotides bind PAZ through a series of backbone
contacts such that nucleotides 3 to 9 are in an RNA helical
conformation with bases exposed for base pairing to the
second single-stranded RNA. If a 20–21-nt single-stranded
RNA is bound to a PAZ domain in the same fashion, the 59
end would be free for other interactions, such as binding to
another protein domain in the RISC or base-pairing to
mRNA. The conformational entropy that results when the 39
end binds to PAZ, because the RNA helix is pre-formed, is
consistent with weaker base pairing between miRNA and
mRNA at the 39 end of the miRNA, and stronger base pairing
at the 59 end. The dimeric structure of the PAZ domain (Ma et
al. 2004) also raises the tantalizing possibility of cooperative
binding of a dimer of two miRNA–PAZ combinations to two
target sites on one or more mRNAs. In such an arrangement,
seven residues at the 39 ends of the two miRNAs (residues 3–9,
but not the terminal two nucleotides) are paired in
antiparallel fashion, with near perfect complementary pair-
ing.
As more details of molecular contacts become available,
prediction rules will evolve and improve in accuracy. The
following elements are worth considering in the next
generation of target prediction rules: (1) details of strand
bias as deduced from siRNA experiments (Khvorova et al.
2003), (2) contribution of sequences outside of the mRNA
target sites, (3) reﬁnement of position-dependent rules,
including different gap penalties for the mRNA and the
miRNA, (4) energetics of miRNA–protein binding, starting
with PAZ domain interaction, and (5) translation of system-
atic mutational proﬁling experiments into scoring rules
(Doench and Sharp 2004).
Principles of Regulation by miRNAs
Although the predicted targets are subject to error (see
estimate of false positives) and the prediction rules in need of
improvement, several general principles of gene regulation
by miRNAs are emerging. (1) Except in cases where a highly
complementary match causes cleavage of the target message,
miRNAs appear to act cooperatively, requiring two or more
target sites per message, for either one or several different
miRNAs. (2) Most miRNAs are involved in the translational
regulation of several target genes, which in some cases are
grouped into functional categories. (3) miRNAs carried in the
context of RNPs appear to be sequence-speciﬁc adaptors
guiding RNPs to particular target sequences. miRNA regu-
lation of cellular messages may therefore range from a switch-
like behavior (e.g., cleavage of mRNA message) to a subtle
modulation of protein dosage in a cell through low-level
translational repression (Bartel and Chen 2004).
These aspects of miRNA regulation complicate the design
of experiments aiming at testing target predictions, or, more
generally, at discovering biologically meaningful targets.
Straightforward experiments that test one target site for
one miRNA on one UTR will not be able to disentangle the
effects of multiplicity or cooperativity. Tests for multiple sites
on one UTR for one miRNA capture aspects of cooperativity
(Doench and Sharp 2004), but still do not capture signal
integration by diverse miRNAs. The most complicated
situation is one in which multiple miRNAs affect multiple
genes in combinatorial fashion, with ﬁne-tuning depending
on the state of the cell. We look forward to the results of
ingenious experiments designed to deal with the complexity
of miRNA regulation.
The results of this genome-wide prediction for mammals
and ﬁsh are meant to be a guide to experiments that will in
time elucidate the genetic control network of regulators of
transcription, translation/maturation, and degradation of
gene products, including miRNAs.
Materials and Methods
miRNA sequences. Mature human and mouse miRNA sequences
were obtained from the RFAM miRNA registry (Grifﬁths-Jones 2004).
To cover cases of incomplete data, any mouse miRNA sequence not
(yet) described in humans was assumed to be present in human, with
the same sequence, and vice versa. Similarly, all mouse miRNAs were
assumed to be identical and present in the rat genome. These
assumptions are reasonable as sequence identity for known orthol-
ogous pairs in human and mouse is, on average, 98% (with 110 out of
146 orthologous sequences being identical). In total, 218 mammalian
miRNAs were used. For human target searches, 162 native miRNA
sequences were available plus 17 mouse and 39 rat miRNA sequences;
for mouse, 191 native, 14 human, and 13 rat sequences; and for rat, 45
native, 159 mouse, and 14 human miRNA sequences.
Mature miRNA sequences for zebraﬁsh and fugu were predicted
starting from known human and mouse miRNA precursor sequences
(Ambros et al. 2003a). Each precursor sequence was used, in a scan
against the zebraﬁsh supercontigs (release 18.2.1) using NCBI
BLASTN (version 2.2.6; E-value cutoff, 2.0) (Altschul et al. 1990), to
identify a sequence segment containing the potential zebraﬁsh
miRNA. The mammalian and ﬁsh segments were then realigned
using a global alignment protocol (ALIGN in the FASTA package,
version 2u65; Pearson and Lipman 1988). After testing the potential
ﬁsh miRNA precursors for foldback structures (Zuker 2003), the ﬁnal
set of 225 predicted zebraﬁsh miRNAs was selected. The same set of
sequences was used for fugu.
39 UTR sequences. The Ensembl database (Birney et al. 2004)
served as the source of genomic data. The Ensembl BioPerl
application user interface was used to generate 39 UTR sequences
for all transcripts of all genes from each genome. Some transcripts
are alternatively spliced from the same gene, so the total number of
genes is smaller than the number of transcripts (Table 3). When no
Ensembl annotated 39 UTR sequences were available, we predicted 39
UTRs by taking 4,000 bp of genomic sequence downstream of the end
of the last exon of a transcript (Table 3). If this predicted region
overlapped coding sequence on either strand, we halted 39 UTR
extension at that point.
UTR orthology and alignment. Orthology mappings between genes
from different genomes were obtained using ‘‘orthologue tables’’
from the EnsMart (Kasprzyk et al. 2004) feature of the Ensembl
database. Pairs of orthologous UTRs were aligned with each other
using the AVID (Bray et al. 2003) alignment algorithm to facilitate
analysis of conservation of position and sequence of target sites. In
total, 26,205 human transcripts, representing 15,869 genes, were
mapped to both mouse and rat transcripts. For zebraﬁsh, 11,442
transcripts, representing 10,909 genes, were mapped to fugu tran-
scripts and 11,306 transcripts mapped to human transcripts (10,063
genes).
miRNA target prediction. The miRanda algorithm (version 1.0;
Enright et al. 2003) was used to scan all available miRNA sequences
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from the Ensembl database and—tabulated separately—against all
cDNA sequences and coding regions. The algorithm uses dynamic
programming to search for maximal local complementarity align-
ments, corresponding to a double-stranded antiparallel duplex. A
score of þ5 was assigned for G:C and A:T pairs, þ2 for G:U wobble
pairs, and  3 for mismatch pairs, and the gap-open and gap-
elongation parameters were set to  8.0 and  2.0, respectively. To
signiﬁcantly increase the speed of miRanda runs, in calculating the
optimal alignment score at positions i, j in the alignment scoring
matrix, the gap-elongation parameter was used only if the extension
to i, j of a given stretch of gaps ending at positions i–1, j or j–1, i (but
not of stretches of gaps ending at i–k, j or j, i–k for k . 1) resulted in a
higher score than the addition of a nucleotide–nucleotide match at
positions i, j. Removal of this restriction with the availability of more
computing power would result in a moderate increase in average
loop length, but the advantages of this would probably be superceded
by overall reﬁnement of target prediction rules. Importantly,
complementarity scores at the ﬁrst eleven positions, counting from
the miRNA 59 end, were multiplied by a scaling factor of 2.0, so as to
approximately reﬂect the experimentally observed 59–39 asymmetry;
for example, G:C and A:T base pairs contributed þ10 to the match
score in these positions. The value of the scaling factor at each
position is an adjustable parameter subject to optimization as more
experimental information becomes available. Because of the ongoing
discussion about the rules for target prediction, target genes (a total
of 490) that contained target sites with more than one G:U wobble in
the 59 end are ﬂagged in the Table S2. The thresholds for candidate
target sites were S . 90 and DG , 17 kcal/mol, where S is the sum of
single-residue-pair match scores over the alignment trace and DG is
the free energy of duplex formation from a completely dissociated
state, calculated using the Vienna package as in Enright et al. (2003).
After ﬁnding optimal local matches above these thresholds
between a particular miRNA and the set of 39 UTRs in each genome,
we asked whether target site position and sequence for this miRNA
were conserved in the 39 UTRs of orthologous genes, i.e., between
human and mouse or rat, or between fugu and zebraﬁsh. The
alignments of target sites were generated transitively
(UTR!miRNA!UTR) via a shared (or homologous) miRNA. We
required that the positions of pairs of target sites in two species fall
within 610 residues in the aligned 39 UTRs. Conserved target sites
with sequence identity of 90% or more (human versus mouse or rat)
and 70% or more (zebraﬁsh versus fugu) were selected as candidate
miRNA target sites and stored in a MySQL database. Using human as
the reference species, we predicted 10,572 conserved target sites
(conserved in either mouse or rat) in 4,463 human transcripts, of
which 2,307 transcripts of 2,273 genes contained more than one
target site. Similarly, using zebraﬁsh as a reference species, we
predicted 7,057 conserved target sites (conserved in fugu) in 4,820
zebraﬁsh transcripts.
To focus on the strongest predictions, conserved target sites for
each miRNA were sorted according to alignment score, with free
energy as the secondary sort criterion. In cases where multiple
miRNAs targeted the same site on a transcript (or within 25 nt of a
site), only the highest scoring, lowest energy miRNA was reported for
that site.
Functional analysis of targets. To facilitate surveys of target
function and analysis of functional enrichment, InterPro domain
assignments (Mulder et al. 2003) and GO (molecular function
hierarchy) mappings (Ashburner and Lewis 2002) for all human
genes were obtained using EnsMart. For each functional class derived
from either source, we calculated its degree of under- or over-
representation, Fclass, using the log-odds ratio of the fraction of
annotated target genes with the same class (F1) and the fraction of all
annotated Ensembl human genes with that class (F2):
Fclass ¼ log2
F1
F2
  
; where F1 ¼
Nclass
tar
X i¼C
i¼1
Ni
tar
and F2 ¼
Nclass
all
X i¼C
i¼1
Ni
all
ð1Þ
Here, N represents the number of genes of a given functional class for
either target genes (Ntar) or all genes (Nall), and C represents the total
number of functional classes. To eliminate bias from small counts we
did not report assignments that were present in less than 1% of all
annotated target genes (F1   0.01 or F2   0.01).
Randomized trials. For each random experiment all miRNAs were
shufﬂed by randomly swapping two bases of a miRNA 1,000 times.
These shufﬂed sequences were then searched against human, mouse,
and rat 39 UTR sequences in the same way described for the main
analysis, including analysis of conservation of target site sequence
and position in orthologous 39 UTRs. A total of ten randomized
experiments were performed. Counts were averaged across all
experiments, and the standard deviation and other statistical
measures were calculated.
Analysis of FMRP-associated mRNAs. We compiled a list of 464
gene identiﬁers of FMRP-associated mRNAs from ﬁve different
publications (Brown et al. 2001; Chen et al. 2003; Denman 2003;
Miyashiro et al. 2003; Waggoner and Liebhaber 2003). Among the
464 gene identiﬁers, 397 identiﬁers were mapped to the correspond-
ing genes in our 39 UTR dataset. The remaining 67 genes were not
mapped because their published identiﬁers were obsolete, primarily
because of their Affymetrix probeset identiﬁcation numbers. To
identify miRNA regulation of the 397 FMRP-associated mRNAs,
these genes were then compared with the set of predicted miRNA
targets.
CPE motif prediction. We predicted CPE motifs in human, mouse,
and rat UTRs. We used a search pattern using four criteria: (1)
presence of the CPE motif UUUUAU, (2) presence of the hexanu-
cleotide AAUAAA, (3) the CPE and the hexanucleotide motif being
within 100 nucleotides of each other, and (4) the conservation of
these motifs and the positions of the motifs in the mouse ortholog
(Mendez and Richter 2001).
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